One2Treat

Pascal Piedbois MD PhD joins One2Treat as chief medical officer to advance patient-centric innovation in clinical trial design and market access

One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.  9 July 2024 -- Brussels, Belgium -- In this new role, Dr Piedbois will ensure the One2Treat suite of offerings are developed and delivered with the requirements of both patients, and the sponsor’s clinical...

One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis

One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches with a pioneering approach that addresses two of the most strategic challenges in the biopharma...
Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium